The Global Veterinary Infectious Disease Diagnostics Market is valued at approximately USD 1.9 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 10.1% over the forecast period 2024-2032. Veterinary Infectious Disease Diagnostics involves the identification and analysis of infectious agents in animals. This field employs various techniques, including serological tests, molecular diagnostics, and culture methods, to detect pathogens such as bacteria, viruses, fungi, and parasites. Accurate diagnostics are crucial for disease management, treatment, and prevention, aiding veterinarians in making informed decisions to protect animal health and public safety. Advanced technologies like PCR and ELISA enhance detection accuracy and speed, contributing to effective control of outbreaks and maintaining the health of livestock and pets.

The market growth is driven by increasing pet ownership and expenditure, which propels the demand for high-quality veterinary care, including diagnostics for infectious diseases. As more people view pets as family members, there is a growing emphasis on early and accurate diagnosis to ensure the well-being of their animals. Additionally, advancements in diagnostic technologies, such as PCR, ELISA, and point-of-care testing, have significantly enhanced the accuracy and speed of diagnosing infectious diseases in animals, leading to better treatment outcomes and increased demand for diagnostic services. Moreover, the rising prevalence of zoonotic diseases has heightened the need for effective diagnostic solutions, driving the market growth as public health concerns grow. However, the high cost of advanced diagnostic tests remains a primary challenge, potentially limiting access to diagnostic services, especially in developing regions where cost constraints are more pronounced. This affordability issue may deter some pet owners and livestock farmers from seeking diagnostic services, affecting overall market growth.

Key regions considered for the global Veterinary Infectious Disease Diagnostics Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominates the market due to the availability of diagnostic products, increasing pet ownership, and rising healthcare expenditure. In contrast, Asia Pacific is expected to grow at the highest rate during the forecast period, driven by the prevalence of various market players and rising awareness among people related to animal health.

Major market players included in this report are:
Zoetis Inc.
Thermo Fisher Scientific
Virbac
Biomerieux SA
Heska Corporation
IDvet
NEOGEN Corporation
QIAGEN N.V.
Randox Laboratories Ltd.
Company 10
The detailed segments and sub-segment of the market are explained below:
By Technology:
Immunodiagnostics
Molecular Diagnostic
Others
By Animal Type:
Companion Animal
Food-producing Animals
By End User:
Reference Laboratories
Veterinary Hospitals & Clinics
Point-of-Care
Research Institutes & Universities
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Middle East & Africa
Saudi Arabia
South Africa
RoMEA
Years considered for the study are as follows:
Historical year - 2022
Base year - 2023
Forecast period - 2024 to 2032
Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.